Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 162,968 | 147,262 | 140,064 | 155,819 | 181,288 |
| Receivables | 293,217 | 280,975 | 260,202 | 310,449 | 347,589 |
| Inventories | 109,475 | 107,537 | 104,813 | 124,722 | 171,123 |
| Other current assets | 33,395 | 50,433 | 54,864 | 55,932 | 14,513 |
| TOTAL | $620,737 | $610,370 | $577,955 | $666,807 | $732,893 |
| Non-Current Assets | |||||
| PPE Net | 334,906 | 339,503 | 322,671 | 322,384 | 363,380 |
| Investments And Advances | 183,200 | 194,461 | 152,162 | 148,733 | 553 |
| Intangibles | 200,447 | 207,992 | 201,758 | 198,154 | 231,514 |
| Other Non-Current Assets | 96,035 | 108,625 | 109,283 | 85,385 | 89,787 |
| TOTAL | $814,588 | $850,582 | $785,874 | $754,656 | $685,234 |
| Total Assets | $1,435,325 | $1,460,951 | $1,363,829 | $1,421,463 | $1,418,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54,277 | 90,649 | 52,720 | 43,600 | 36,979 |
| Accounts payable and accrued liabilities | 110,532 | 104,938 | 103,213 | 121,046 | 126,364 |
| Other current liabilities | 122,879 | 124,921 | 162,427 | 213,860 | 166,441 |
| TOTAL | $427,602 | $467,770 | $398,886 | $469,436 | $429,447 |
| Non-Current Liabilities | |||||
| Long Term Debt | 378,661 | 399,370 | 434,513 | 419,198 | 445,473 |
| Other Non-Current Liabilities | 35,398 | 37,252 | 35,812 | 31,422 | 36,519 |
| TOTAL | $446,866 | $469,185 | $507,728 | $491,314 | $521,820 |
| Total Liabilities | $874,468 | $936,955 | $906,614 | $960,751 | $951,267 |
| Shareholders' Equity | |||||
| Common Shares | 40,884 | 41,550 | 33,708 | 31,451 | 32,060 |
| Other shareholders' equity | 329,582 | 315,086 | 276,679 | 291,325 | 298,704 |
| TOTAL | $560,857 | $523,996 | $457,215 | $460,713 | $466,860 |
| Total Liabilities And Equity | $1,435,325 | $1,460,951 | $1,363,829 | $1,421,463 | $1,418,127 |